Stock TRANSPACT TRANSPACT ENTERPRISES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Transpact Enterprises Limited

Equities

TRANSPACT

INE06YD01010

Advanced Medical Equipment & Technology

Market Closed - Bombay S.E.
Other stock markets
 06:00:54 2024-05-24 am EDT 		5-day change 1st Jan Change
325.8 INR -4.99% Intraday chart for Transpact Enterprises Limited -.--% -15.36%
Mar. 14 Transpact Enterprises Limited Approves Appointment of Ms. Amrita Gupta as the Company Secretary and Compliance Officer CI
Mar. 07 Transpact Enterprises Limited Announces Resignation of Damini Baid as Woman Additional Independent Director CI

Valuation

Fiscal Period: March 2020 2021 2022 2023
Capitalization 1 52.21 62.65 57.35 36.74
Enterprise Value (EV) 1 54.73 65.06 60.09 39.39
P/E ratio -10.7 x -97.6 x -26 x -55.8 x
Yield - - - -
Capitalization / Revenue - 250,601,040 x 38,234,706 x 9,605,059 x
EV / Revenue - 260,246,740 x 40,057,373 x 10,297,346 x
EV / EBITDA -13,493,976 x -164,601,864 x -27,090,198 x -79,570,404 x
EV / FCF -23.5 x 195 x 160 x 116 x
FCF Yield -4.25% 0.51% 0.63% 0.86%
Price to Book 5.9 x 7.64 x 9.57 x 6.89 x
Nbr of stocks (in thousands) 387 387 387 387
Reference price 2 135.0 162.0 148.3 95.00
Announcement Date 9/7/20 9/7/21 9/8/22 9/7/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales - 1.3 - 0.25 1.5 3.825
EBITDA - -0.414 -4.056 -0.3953 -2.218 -0.495
EBIT 1 -0.915 -0.591 -4.233 -0.5902 -2.395 -0.672
Operating Margin - -45.46% - -236.08% -159.67% -17.57%
Earnings before Tax (EBT) 1 -0.915 -0.59 -4.233 -0.5906 -2.195 -0.673
Net income 1 -0.915 -0.71 -4.334 -0.6417 -2.209 -0.659
Net margin - -54.62% - -256.7% -147.27% -17.23%
EPS 2 -3.240 -2.511 -12.62 -1.660 -5.712 -1.703
Free Cash Flow 1 -2.024 -1.065 -2.325 0.3336 0.3761 0.339
FCF margin - -81.95% - 133.46% 25.08% 8.86%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/26/19 8/19/19 9/7/20 9/7/21 9/8/22 9/7/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 0.49 1.77 2.52 2.41 2.73 2.65
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - -4.278 x -0.6221 x -6.101 x -1.233 x -5.349 x
Free Cash Flow 1 -2.02 -1.07 -2.33 0.33 0.38 0.34
ROE (net income / shareholders' equity) -37.6% -24.7% -76.3% -7.53% -31.1% -11.6%
ROA (Net income/ Total Assets) -16.2% -7.47% -29% -2.75% -12.1% -3.91%
Assets 1 5.646 9.505 14.95 23.37 18.31 16.84
Book Value Per Share 2 11.40 0.0600 22.90 21.20 15.50 13.80
Cash Flow per Share 2 2.070 0.2400 0.2100 1.350 0.5200 0.3500
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 6/26/19 8/19/19 9/7/20 9/7/21 9/8/22 9/7/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
TRANSPACT ENTERPRISES LIMITED Stock Transpact Enterprises Limited
-15.36% 1.51M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.01% 217B
DANAHER CORPORATION Stock Danaher Corporation
+11.01% 190B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+19.20% 143B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.79% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.48% 64.59B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.95% 52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.16% 48.45B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.20% 38.03B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.91% 35.61B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. TRANSPACT Stock
  4. Financials Transpact Enterprises Limited